I beg to move,
That leave be given to bring in a Bill to require community pharmacies and other providers of NHS-funded prescriptions to show, on the patient label, the prevailing Drug Tariff value of the items dispensed; and for connected purposes.
I would like to declare that my wife is a community pharmacist and, as would be expected, she has offered me some assistance in considering this Bill. I would like to thank Mr Gurpal Singh Chaggar of Newington pharmacy in Ramsgate in my constituency for his help and support with some of the more technical aspects of how the published NHS drug tariff—amended monthly and, for some items, more frequently—interfaces with software used in all pharmacies. I also thank the House of Commons Library, as ever, for its professional assistance, which it can always be relied upon for.
This Bill has the benefit of elegance, simplicity and, quite rarely for this place, a cost and administration burden as close to zero as any measure could possibly have. Let me lay out the framework for the Bill with some facts. In 2021-22 there were 1.14 billion items dispensed through NHS England, serving a population of 56 million—I will leave Members to do the maths for how many prescriptions per person that amounts to. The cost of the items dispensed, which cover pharmaceutical products and more physical appliances and dressings, was £8.7 billion. Just 11% of all prescriptions bear the current £9.35 prescription fee. If we look at that the other way, 89% of all prescriptions are “free”, but of course, nothing is free. There are a multitude of exemptions—for example, the over-60s, those in receipt of benefits, the under-18s, those in education and those with certain medical conditions. We are all familiar with those.
The prescription fees received in 2018-19—the last year for which the Library could provide me evidence—when the prescription charge was £8.80, were £576 million. By extrapolation, given that people now pay £9.35 for a prescription, I estimate that that figure would be a little north of £600 million today. That means that the prescription system is recovering £600 million out of an overall cost of £8.7 billion.
The bulk of prescription charges comes from those paying for off-patent drugs, for which the cost price may sometimes, marginally, be less than the prescription charge. Such off-patent drugs—often the slightly cheaper generic products—make up about a quarter of all prescriptions in England and include blood pressure drugs, cholesterol-lowering drugs, antibiotics, anti-depressants, skin creams, drugs for rheumatism, oral contraceptives and analgesics.
The main purpose of the Bill is twofold. Primarily, it will allow everyone in receipt of NHS-provided prescriptions to be part of the efficiency measures that the nation needs now, and I think it is fair to ask us all to do our bit. For instance, no one keeps a window open on a winter’s day and then heats the room, or throws food away by design, so why should it be normal, reasonable and ongoing for perfectly good medication to be unused and thrown away?